Valerie Palmieri was appointed President and Chief Executive Officer in January 2015, prior to joining Aspira Women's Health as Chief Operating Officer in October 2014.
During her tenure at Aspira Women’s Health Valerie led the transition of the company to the commercialization of its market-leading products and is now focused on the company’s product expansion pipeline into benign pelvic mass management and endometriosis.
Valerie brings to Aspira Women's Health more than 30 years of experience in the diagnostic laboratory industry, serving in numerous sales, operations, and executive leadership positions for both laboratory service and consulting organizations. Before joining Aspira Women's Health, Palmieri was CEO/President of MOMENTUM Consulting. She also served as CEO/President of two healthcare start-ups that resulted in a successful exit for one and won her recognition as one of the “Top 10 Entrepreneurs of Springboard Enterprises” for the other. She spent six years as National Vice President of Anatomic Pathology Operations with LabCorp, the successor company to DIANON Systems where she served as Senior Vice President of Operations and was a key leader in the sale of DIANON to LabCorp in 2003. Palmieri holds a Bachelor of Science degree in medical technology from Western Connecticut State University.